logo
Select company
Select metric
26.92%Inventory to Assets Ratio
VS
Market
6
Sector
3
Industry
1
History
13
$ 2.37Close
$ 1.02 - $ 3.07 52-Week Range
Ticker Information

Ticker

PLX

Company Name

PROTALIX BIOTHERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

PROTALIX BIOTHERAPEUTICS INC - Inventory to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PLX - Inv. to Assets Historical data
DateTotal AssetsInventoryInventory to Assets Ratio
6/30/2025$ 78.49M$ 21.13M26.92%
3/31/2025$ 73.89M$ 19.51M26.4%
12/31/2024$ 73.42M$ 21.24M28.93%
9/30/2024$ 61.56M$ 17.2M27.94%
6/30/2024$ 91.54M$ 20.72M22.63%
3/31/2024$ 89.83M$ 22.35M24.88%
12/31/2023$ 84.43M$ 19.05M22.56%
9/30/2023$ 87.57M$ 21.58M24.65%
6/30/2023$ 88.42M$ 19.64M22.21%
3/31/2023$ 66.56M$ 20.3M30.5%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PROTALIX BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) Inv. to Assets stands at 18.37%.
  • Over the past 5 years, PROTALIX BIOTHERAPEUTICS INC's average Inv. to Assets has been 23.53%.
  • The median Inv. to Assets for PROTALIX BIOTHERAPEUTICS INC during this period was 24.51%
  • PROTALIX BIOTHERAPEUTICS INC reached its highest Inv. to Assets over the past 5 years at 30.5%.
  • The lowest Inv. to Assets recorded by PROTALIX BIOTHERAPEUTICS INC in the same timeframe 12.61%

PROTALIX BIOTHERAPEUTICS INC's Inv. to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Inv. to Assets Benchmarks
CompanyInv. to Assets
CSBR : CHAMPIONS ONCOLOGY INC 0%THTX : THERATECHNOLOGIES INC 14.85%BDTX : BLACK DIAMOND THERAPEUTICS INC 0%SPRO : SPERO THERAPEUTICS INC 0%ENTA : ENANTA PHARMACEUTICALS INC 0%CELU : CELULARITY INC 9.83%IVVD : INVIVYD INC 28.54%DOMH : DOMINARI HOLDINGS INC 0%SGMO : SANGAMO THERAPEUTICS INC 0%ALEC : ALECTOR INC 0%

Definition of Inventory to Assets Ratio

[Calculation] [Inventory] as percentage of total [Assets], serves as an efficiency ratio - the lower the better.
Inventory / Assets
(=) Inv. to Assets
Inv. to Assets for PROTALIX BIOTHERAPEUTICS INC is calculated as follows: Inventory [ $ 13.28M ] / Assets [ $ 72.31M ]
(=) Inv. to Assets [ 18.37% ]

PLX - Inventory to Assets Ratio, Last 5 years

12.61%

Minimum

Jun 30, 2021

30.5%

Maximum

Mar 31, 2023

23.53%

Average

24.51%

Median

Inv. to Assets Benchmark Analysis

The chart above depicts the distribution of Inv. to Assets for companies in the Total Stock Market. The average Inv. to Assets of the companies is 6.08% with a standard deviation of 11.1%.
The following table provides additional summary stats:
Inv. to Assets in the Market:
filtered constituents4.46K
min0%
max98.39%
average6.08%
median0%
std11.1%